-
1
-
-
0033772113
-
Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors
-
Wolozin B, Kellman W, Ruosseau P, Celesia GG, Siegel G. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Arch Neurol 2000; 57: 1439-43.
-
(2000)
Arch Neurol
, vol.57
, pp. 1439-1443
-
-
Wolozin, B.1
Kellman, W.2
Ruosseau, P.3
Celesia, G.G.4
Siegel, G.5
-
2
-
-
0035834416
-
CNS synaptogenesis promoted by glia-derived cholesterol
-
Mauch DH, Nagler K, Shumacher S. CNS synaptogenesis promoted by glia-derived cholesterol. Science 2001; 294: 1354-7.
-
(2001)
Science
, vol.294
, pp. 1354-1357
-
-
Mauch, D.H.1
Nagler, K.2
Shumacher, S.3
-
3
-
-
3543104951
-
Thematic review series: Brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal
-
Dietschy JM, Turley SD. Thematic review series: brain Lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J Lipid Res 2004; 45: 1375-97.
-
(2004)
J Lipid Res
, vol.45
, pp. 1375-1397
-
-
Dietschy, J.M.1
Turley, S.D.2
-
4
-
-
0034969390
-
Do sterols reduce proton and sodium leaks through lipid bilayers?
-
Haines TH. Do sterols reduce proton and sodium leaks through lipid bilayers? Prog Lipid Res 2001; 40: 299-324.
-
(2001)
Prog Lipid Res
, vol.40
, pp. 299-324
-
-
Haines, T.H.1
-
5
-
-
0032740439
-
Cholesterol accumulation in tissues of the Niemann-pick type C mouse is determined by the rate of lipoprotein-cholesterol uptake through the coated-pit pathway in each organ
-
Xie C, Turley SD, Dietscy JM. Cholesterol accumulation in tissues of the Niemann-pick type C mouse is determined by the rate of lipoprotein-cholesterol uptake through the coated-pit pathway in each organ. Proc Natl Acad Sci USA 1999; 96: 11992-7.
-
(1999)
Proc Natl Acad Sci USA
, vol.96
, pp. 11992-11997
-
-
Xie, C.1
Turley, S.D.2
Dietscy, J.M.3
-
6
-
-
0037040184
-
Control of cholesterol turnover in the mouse
-
Dietschy JM, Turley SD. Control of cholesterol turnover in the mouse. J Biol Chem 2002; 277: 3801-4.
-
(2002)
J Biol Chem
, vol.277
, pp. 3801-3804
-
-
Dietschy, J.M.1
Turley, S.D.2
-
7
-
-
0038265008
-
Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover
-
Lund EG, Xie C, Kotti T. Knockout of the cholesterol 24-hydroxylase gene in mice reveals a brain-specific mechanism of cholesterol turnover. J Biol Chem 2003; 278: 22980-8.
-
(2003)
J Biol Chem
, vol.278
, pp. 22980-22988
-
-
Lund, E.G.1
Xie, C.2
Kotti, T.3
-
8
-
-
0034705221
-
Better outcome after stroke with higher serum cholesterol levels
-
Vauthey C, de Freitas GR, van Melle G. Better outcome after stroke with higher serum cholesterol levels. Neurology 2000; 54: 1944-9.
-
(2000)
Neurology
, vol.54
, pp. 1944-1949
-
-
Vauthey, C.1
de Freitas, G.R.2
van Melle, G.3
-
9
-
-
0032568552
-
Cholesterol depletion inhibits the generation of beta- amyloid in hippocampal neurons
-
Simons K, Keller P, De Strooper B. Cholesterol depletion inhibits the generation of beta- amyloid in hippocampal neurons. Proc Natl Acad Sci USA 1998; 95: 6460-4.
-
(1998)
Proc Natl Acad Sci USA
, vol.95
, pp. 6460-6464
-
-
Simons, K.1
Keller, P.2
De Strooper, B.3
-
10
-
-
0037421206
-
Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts
-
Ehehalt R, Keller P, Haass C, Thiele C, Simons K. Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J Cell Biol 2003; 160: 113-23.
-
(2003)
J Cell Biol
, vol.160
, pp. 113-123
-
-
Ehehalt, R.1
Keller, P.2
Haass, C.3
Thiele, C.4
Simons, K.5
-
11
-
-
0141482022
-
Exclusively targeting beta-secretase to lipid rafts by GPI-anchor addition up-regulates beta-site processing of the amyloid precursor protein
-
Cordy JM, Hussain I, Dingwall C, Hooper NM, Turner AJ. Exclusively targeting beta-secretase to lipid rafts by GPI-anchor addition up-regulates beta-site processing of the amyloid precursor protein. Proc Natl Acad Sci USA 2003; 100: 11735-40.
-
(2003)
Proc Natl Acad Sci USA
, vol.100
, pp. 11735-11740
-
-
Cordy, J.M.1
Hussain, I.2
Dingwall, C.3
Hooper, N.M.4
Turner, A.J.5
-
12
-
-
0034307463
-
The human DI-MINUTO/DWARF1 homolog seladin-1 confers resistance to Alzheimer's disease-associated neurodegeneration and oxidative stress
-
Greeve I, Hermans-Borgmayer I, Brellinger C. The human DI-MINUTO/DWARF1 homolog seladin-1 confers resistance to Alzheimer's disease-associated neurodegeneration and oxidative stress. J Neurosci 2000; 20: 7345-52.
-
(2000)
J Neurosci
, vol.20
, pp. 7345-7352
-
-
Greeve, I.1
Hermans-Borgmayer, I.2
Brellinger, C.3
-
13
-
-
0142106462
-
Proteomic characterisation of neuronal sphingolipid cholesterol microdomains: Role in plasminogen activation
-
Ledesma MD, Da Silva JS, Shevchenko A. Proteomic characterisation of neuronal sphingolipid cholesterol microdomains: role in plasminogen activation. Brain Res 2003; 987: 107-16.
-
(2003)
Brain Res
, vol.987
, pp. 107-116
-
-
Ledesma, M.D.1
Da Silva, J.S.2
Shevchenko, A.3
-
14
-
-
10344263931
-
Neuronal membrane cholesterol loss enhances amyloid peptide generation
-
Abad-Rodriguez J, Ledesma MD, Craessaerts K. Neuronal membrane cholesterol loss enhances amyloid peptide generation. J Cell Biol 2004; 167: 953-60.
-
(2004)
J Cell Biol
, vol.167
, pp. 953-960
-
-
Abad-Rodriguez, J.1
Ledesma, M.D.2
Craessaerts, K.3
-
15
-
-
0346463111
-
Raft disorganization leads to reduced plasmin activity in Alzheimer's disease brains
-
Ledesma MD, Abad-Rodriguez J, Galvan C. Raft disorganization leads to reduced plasmin activity in Alzheimer's disease brains. EMBO Rep 2003; 4: 1190-6.
-
(2003)
EMBO Rep
, vol.4
, pp. 1190-1196
-
-
Ledesma, M.D.1
Abad-Rodriguez, J.2
Galvan, C.3
-
16
-
-
0036964776
-
HMG-CoA reductase inhibitors (statins) in the treatment of Alzheimer's disease and why it would be ill-advise to use one that crosses the blood-brain barrier
-
Sparks DL, Connor DJ, Browne PJ. HMG-CoA reductase inhibitors (statins) in the treatment of Alzheimer's disease and why it would be ill-advise to use one that crosses the blood-brain barrier. J Nutr Health Aging 2002; 6: 324-31.
-
(2002)
J Nutr Health Aging
, vol.6
, pp. 324-331
-
-
Sparks, D.L.1
Connor, D.J.2
Browne, P.J.3
-
17
-
-
0034896748
-
Alzheimer's disease: Molecular concepts and therapeutic targets
-
Fassbender K, Masters C, Beyreuther K. Alzheimer's disease: molecular concepts and therapeutic targets. Naturwissenschaften 2001; 88: 261-7.
-
(2001)
Naturwissenschaften
, vol.88
, pp. 261-267
-
-
Fassbender, K.1
Masters, C.2
Beyreuther, K.3
-
18
-
-
0035875462
-
Use of statins in CNS disorders
-
Cucchiara B, Kasner SE. Use of statins in CNS disorders. J Neurol Sci 2001; 187: 81-9.
-
(2001)
J Neurol Sci
, vol.187
, pp. 81-89
-
-
Cucchiara, B.1
Kasner, S.E.2
-
19
-
-
0028267313
-
Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial
-
Waters D, Higginson L, Gladstone P. Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial. Circulation 1994; 89: 959-68.
-
(1994)
Circulation
, vol.89
, pp. 959-968
-
-
Waters, D.1
Higginson, L.2
Gladstone, P.3
-
20
-
-
18044379899
-
The "Statinth" wonder of the world: A panacea for all illnesses or a bubble about to burst
-
Shafig N, Malhotra S, Pandhi P. The "Statinth" wonder of the world: a panacea for all illnesses or a bubble about to burst. J Negat Results Biomed 2005; 4: 3.
-
(2005)
J Negat Results Biomed
, vol.4
, pp. 3
-
-
Shafig, N.1
Malhotra, S.2
Pandhi, P.3
-
21
-
-
21444445440
-
Statins cause intracellular accumulation of amyloid precursorprotein, beta-secretase-cleaved fragments, and amyloid beta-peptide via an isoprenoid-dependent mechanism
-
Cole SL, Grudzien A, Manhart IO. Statins cause intracellular accumulation of amyloid precursorprotein, beta-secretase-cleaved fragments, and amyloid beta-peptide via an isoprenoid-dependent mechanism. J Biol Chem 2005; 280: 18755-70.
-
(2005)
J Biol Chem
, vol.280
, pp. 18755-18770
-
-
Cole, S.L.1
Grudzien, A.2
Manhart, I.O.3
|